Literature DB >> 28319574

MELF Pattern for Predicting Lymph Node Involvement and Survival in Grade I-II Endometrioid-type Endometrial Cancer.

Muzaffer Sanci1, Kemal Güngördük, Varol Gülseren, Tuğba Karadeniz, Mustafa Kocaer, Ozgu Gungorduk, İsa A Özdemir.   

Abstract

The aim of this study was to examine the associations between microcystic, elongated, and fragmented (MELF) pattern and other prognostic factors and lymph node involvement, disease-free survival, and overall survival (OS) using a case-control group consisting of grade I-II endometrioid endometrial carcinoma (EEC) patients with/without lymph node involvement. The files of the patients were searched electronically for all hysterectomy specimens with a diagnosis of grade I-II EEC of the uterine body from January 1, 2008 to July 31, 2014. Lymph node involvement was detected in 27 patients who were histologically diagnosed with grade I-II EEC, and these patients made up the case group. Using a dependent random sampling method, 28 grade I-II EEC patients without lymph node involvement were selected. According to multivariate regression analysis, lymphovascular space invasion [odds ratio, 23.5; 95% confidence interval (CI), 2.4-223.5] and MELF pattern (odds ratio, 13.3; 95% CI, 1.4-121.8) were significant predictors of lymph node involvement. There was recurrence in 15.8% of cases that showed a MELF pattern and in 19.4% of those that did not (P=0.738). According to Kaplan-Meier analysis, the MELF pattern revealed no significant differences in disease-free survival (hazard ratio, 1.0; 95% CI, 0.1-36.5), whereas the effect on OS was significant (hazard ratio, 2.2; 95% CI, 1.3-4.2). The presence of MELF pattern was a substantial risk factor for detecting lymph node involvement in patients with grade I-II EEC. The MELF pattern may be important for identifying which patients need staging surgery, in addition to its effect on the OS.

Entities:  

Mesh:

Year:  2018        PMID: 28319574     DOI: 10.1097/PGP.0000000000000370

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  11 in total

1.  Disseminated tumor cells are not associated with established risk factors, L1CAM immunoreactivity and outcome in endometrial carcinoma.

Authors:  Stefan Kommoss; Andreas D Hartkopf; Bernhard Krämer; Anne-Kathrin Bunz; Friederike Grevenkamp; Felix Kommoss; Jana Pasternak; Sabine M Arbabi; Markus Wallwiener; Annette Staebler; Sigurd F Lax; Sara Y Brucker; Florin-Andrei Taran
Journal:  J Cancer Res Clin Oncol       Date:  2017-07-14       Impact factor: 4.553

2.  Endometrial Tumour Microenvironment.

Authors:  Carlos Casas-Arozamena; Miguel Abal
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

3.  Clinicopathological and Molecular Differences Between Gastric-type Mucinous Carcinoma and Usual-type Endocervical Adenocarcinoma of the Uterine Cervix.

Authors:  Hera Jung; Go Eun Bae; Hye Min Kim; Hyun-Soo Kim
Journal:  Cancer Genomics Proteomics       Date:  2020 Sep-Oct       Impact factor: 4.069

4.  Tumor-Associated T-Lymphocytes and Macrophages are Decreased in Endometrioid Endometrial Carcinoma with MELF-Pattern Stromal Changes.

Authors:  Dmitry Aleksandrovich Zinovkin; Md Zahidul Islam Pranjol; Il'ya Andreevich Bilsky; Valeriya Alexandrovna Zmushko
Journal:  Cancer Microenviron       Date:  2018-07-14

5.  Overexpression of the matrix metalloproteinase 11 gene is a potential biomarker for type 1 endometrial cancer.

Authors:  Gabriela Sofía Gómez-Macías; María Lourdes Garza-Rodríguez; Raquel Garza-Guajardo; Daniela Monsiváis-Ovalle; Jesús Ancer-Rodríguez; Hugo Alberto Barrera-Saldaña; Oralia Barboza-Quintana
Journal:  Oncol Lett       Date:  2018-05-16       Impact factor: 2.967

6.  Clinicopathologic Association and Prognostic Value of MELF Pattern in Invasive Endocervical Adenocarcinoma (ECA) as Classified by IECC.

Authors:  Sheila E Segura; Lien Hoang; Monica Boros; Cristina Terinte; Anna Pesci; Sarit Aviel-Ronen; Takako Kiyokawa; Isabel Alvarado-Cabrero; Esther Oliva; Kay J Park; Robert A Soslow; Simona Stolnicu
Journal:  Int J Gynecol Pathol       Date:  2020-09       Impact factor: 3.326

7.  High Expression of Galectin-1, VEGF and Increased Microvessel Density Are Associated with MELF Pattern in Stage I-III Endometrioid Endometrial Adenocarcinoma.

Authors:  Dmitry Aleksandrovich Zinovkin; Sergey Leonidovich Achinovich; Mikhail Grigoryevich Zubritskiy; Jacqueline Linda Whatmore; Md Zahidul Islam Pranjol
Journal:  J Pathol Transl Med       Date:  2019-06-27

8.  The effect of myometrial invasion on prognostic factors and survival analysis in endometrial carcinoma.

Authors:  Cem Dane; Sait Bakir
Journal:  Afr Health Sci       Date:  2019-12       Impact factor: 0.927

9.  Myoinvasive Pattern as a Prognostic Marker in Low-Grade, Early-Stage Endometrioid Endometrial Carcinoma.

Authors:  Ignacio Ruz-Caracuel; Jorge L Ramón-Patino; Álvaro López-Janeiro; Laura Yébenes; Alberto Berjón; Alicia Hernández; Alejandro Gallego; Victoria Heredia-Soto; Marta Mendiola; Andrés Redondo; Alberto Peláez-García; David Hardisson
Journal:  Cancers (Basel)       Date:  2019-11-22       Impact factor: 6.639

10.  Usual-Type Endocervical Adenocarcinoma with a Microcystic, Elongated, and Fragmented Pattern of Stromal Invasion: A Case Report with Emphasis on Ki-67 Immunostaining and Targeted Sequencing Results.

Authors:  Sangjoon Choi; Soohyun Hwang; Sung-Im Do; Hyun-Soo Kim
Journal:  Case Rep Oncol       Date:  2020-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.